Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European- Australian phase 3 trial - Khullar, V; Amarenco, G; Angulo, JC (Eur Urol, 2013)
et al.